Search Results

All Content Formulary Only Other Content

Scottish Formulary has compiled the following search results: We have found 32 results when searching "Rituximab"

FORMULARY DECISION

Rituximab : MabThera

330/06 : Relapsed/refractory follicular lymphoma

FORMULARY DECISION

Rituximab : MabThera

TA243 (SMC 493/08) : For the treatment of previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy

FORMULARY DECISION

Rituximab : MabThera

540/09 : Chronic Lymphocytic Leukaemia (CLL)

FORMULARY DECISION

Rituximab : MabThera

675/11 : Follicular lymphoma patients responding to induction therapy

FORMULARY DECISION

894/13 : In combination with glucocorticoids for the induction of remission in adult patients with severe, active granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA).

FORMULARY DECISION

Rituximab : MabThera

975/14 : For non-Hodgkin' s lymphoma (NHL) in adults: - previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy; - maintenance therapy is indicated for the...

FORMULARY DECISION

Rituximab : MabThera

SMC2165 : In combination with glucocorticoids, for the treatment of adult patients with severe, active granulomatosis with polyangiitis (Wegener’s) (GPA) and microscopic polyangiitis (MPA).

FORMULARY DECISION

Rituximab : MabThera

SMC2193 : Treatment of patients with moderate to severe pemphigus vulgaris.

FORMULARY DECISION

Rituximab : MabThera

In combination with bendamustine for first-line treatment of chronic lymphocytic leukaemia.